Latest News for: hemophilia b
Edit
Pfizer says patient in hemophilia drug study died after serious side effects
Saudi Gazette 24 Dec 2025
Edit
SonoThera Presents New Data at ASH 2025 Demonstrating Durable Factor VIII Expression Using Ultrasound Mediated Gene Delivery in Treating Hemophilia A
Pharmiweb 09 Dec 2025
Where current approved therapies for Hemophilia> A are limited by variable expression, unfavorable durability, and immunogenicity, UMD has, thus far, shown its ability to address these challenges, and we look forward to sharing this data.” ... Session ... .
Edit
What Trends Are Defining the Hemophilia Inhibitors Market Growth?
Nasdaq Globe Newswire 04 Dec 2025
According to market research the hemophilia inhibitors market growth is driven by emerging trends and strong demand across key sectors ... .
Edit
Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight
PR Newswire 03 Dec 2025
Edit
Hemophilia Research Analysis Report 2025-2035: Market Advances as Leading Players Accelerate Gene Therapy Innovation and ...
Nasdaq Globe Newswire 18 Nov 2025
The global hemophilia market is experiencing robust growth, fueled by advances in gene therapy and recombinant clotting factors ... therapeutic solutions, poised to reshape hemophilia management globally.
Edit
14th World Federation of Hemophilia Global Forum Presentation (Inovio Pharmaceuticals Inc)
Public Technologies 14 Nov 2025
). Novel FVIII Secretion Via Non-Viral Vector DNA Medicine Platform. Laurent M. Humeau,. Chief Scientific Officer. November 14, 2025 ... TARGET ... 3 ... Long-term in vivo protein expression remains a sought-after goal for genetic disorders such as Hemophilia> ... (noodl.
Edit
The Eagle-Tribune
11 Nov 2025
Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting
MGX-001 demonstrated curative FVIII activity in non-human primates ... .
Edit
Metagenomi Presents New Preclinical Data from MGX-001 Hemophilia A Program Supporting Advancement into Clinical Development
Nasdaq Globe Newswire 11 Nov 2025
MGX-001 demonstrated curative FVIII activity in non-human primates ... .
Edit
GeneVentiv Therapeutics Announces Positive FDA INTERACT Feedback Supporting Advancement of GENV-HEM Gene Therapy for Hemophilia A with or without Inhibitors
PR Newswire 29 Oct 2025
Food and Drug Administration (FDA) for the Company's lead program, GENV-HEM, a novel gene therapy for Hemophilia> A with or without inhibitors (antibodies to Factor VIII).
Edit
Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering
Nasdaq Globe Newswire 22 Oct 2025
.
Edit
Rural Gambians with hemophilia struggle amid shortage of trained medical staff
The Point 22 Oct 2025
Growing concerns over the lack of adequate healthcare services and the shortage of trained medical professionals in rural Gambia took center stage at the Safe Motherhood and Hemophilia> Foundation’s Family Day held at the Badala Park Hotel.
Edit
Sindh launches annual Hemophilia Prophylaxis Therapy at Nazimabad centre
Urdu Point 17 Oct 2025
Durenaz Jamal for their steadfast leadership and continued commitment to the hemophilia community.</p><p>“Dr. Durenaz Jamal is truly a queen and an angel for the hemophilia and bleeding disorder community,” Raheel said.
Edit
Acquired Hemophilia A Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ...
GetNews 16 Oct 2025
Edit
Hemophilia B Pipeline Drugs Report 2025: Exploring Emerging Therapies and Innovative Drug Developments Across Key Indications
GetNews 08 Oct 2025
Inactive Products Hemophilia> B Key Companies Hemophilia B Key Products Hemophilia B - Unmet Needs Hemophilia B - Market Drivers and Barriers Hemophilia B - Future Perspectives and Conclusion ...
- 1
- 2
- Next page »